Brimonidine
From Wikipedia, the free encyclopedia
 |
|
|
Brimonidine
|
|
| Systematic (IUPAC) name | |
| 5-bromo-N- (4,5-dihydro-1H-imidazol-2-yl) quinoxalin-6-amine | |
| Identifiers | |
| CAS number | 59803-98-4 |
| ATC code | S01EA05 |
| PubChem | 2435 |
| DrugBank | APRD00034 |
| Chemical data | |
| Formula | C11H10BrN5 |
| Mol. weight | 292.135 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 2 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Brimonidine (bri-MOE-ni-deen ) is a drug used to treat glaucoma. It acts via decreasing aqueous humor synthesis.
Brimonidine is an alpha receptor agonist.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
| Antiglaucoma preparations and miotics (S01E) edit | ||
|---|---|---|
| Sympathomimetics: |
Apraclonidine, Brimonidine, Clonidine, Dipivefrine, Epinephrine |
|
| Parasympathomimetics: |
Aceclidine, Acetylcholine, Carbachol, Demecarium, Echothiophate, Fluostigmine, Neostigmine, Paraoxon, Physostigmine, Pilocarpine |
|
| Carbonic anhydrase inhibitors: |
Acetazolamide, Brinzolamide, Diclofenamide, Dorzolamide, Methazolamide |
|
| Beta blocking agents: |
Befunolol, Betaxolol, Carteolol, Levobunolol, Metipranolol, Timolol |
|
| Prostaglandin analogues: |
Bimatoprost, Latanoprost, Travoprost, Unoprostone |
|
| Other agents: |
Dapiprazole, Guanethidine |
|
